Nerano Pharma’s Strategic Funding Partnership With Advanced Oncotherapy plc

Macfarlanes has advised Nerano Pharma Limited on the provision of an interest-bearing secured convertible facility to Advanced Oncotherapy plc. Advanced Oncotherapy will use the funding to…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Paolo Bossi

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here